News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
News Industry News New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients September 15, 2014
News Industry News Promising Preliminary Data Show Abbott's Innovative Testing Platform May Identify Life-Threatening Infections Faster Than Current Methods May 12, 2014